Genentech’s Personalized Medicine Entrectinib Shrank Tumors Harboring NTRK, ROS1
- This topic has 0 replies, 1 voice, and was last updated 4 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Genentech’s Personalized Medicine Entrectinib Shrank Tumors Harboring NTRK, ROS1 or ALK Gene Fusions in Children and Adolescents
https://www.apnews.com/Business%20Wire/184790307924497dbde1c14bb03cdc46
Viewing 1 post (of 1 total)
- The forum ‘Websites’ is closed to new topics and replies.